[
  {
    "ts": "2025-12-05T02:48:10+00:00",
    "headline": "Pfizer Inc. (PFE): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Pfizer Inc. on HatedMoats’s Substack. In this article, we will summarize the bulls’ thesis on PFE. Pfizer Inc.’s share was trading at $25.27 as of December 1st. PFE’s trailing and forward P/E were 14.97 and 8.50 respectively according to Yahoo Finance. Pfizer Inc. (PFE) has emerged from the post-COVID period as a transformed […]",
    "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-bull-case-024810028.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5ae0dd83-34c4-3fe2-87a5-8c3f940ac1e1",
      "content": {
        "id": "5ae0dd83-34c4-3fe2-87a5-8c3f940ac1e1",
        "contentType": "STORY",
        "title": "Pfizer Inc. (PFE): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Pfizer Inc. on HatedMoats’s Substack. In this article, we will summarize the bulls’ thesis on PFE. Pfizer Inc.’s share was trading at $25.27 as of December 1st. PFE’s trailing and forward P/E were 14.97 and 8.50 respectively according to Yahoo Finance. Pfizer Inc. (PFE) has emerged from the post-COVID period as a transformed […]",
        "pubDate": "2025-12-05T02:48:10Z",
        "displayTime": "2025-12-05T02:48:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3052554a5673500b2147b2f3c83a2fd5",
          "originalWidth": 768,
          "originalHeight": 509,
          "caption": "Analyst Says Pfizer (PFE) Stock Will ‘Move Too Fast to Catch’",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pg1ruI8jmytZrC3KfUN.Ng--~B/aD01MDk7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3052554a5673500b2147b2f3c83a2fd5.cf.webp",
              "width": 768,
              "height": 509,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LMsGcyNZ22D5ZdRWNHAfRw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3052554a5673500b2147b2f3c83a2fd5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-bull-case-024810028.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-bull-case-024810028.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]